SHARE:

< Back to Search

Neurology® Podcast - October 2 2007 Issue

Incidence and clinical significance of antibodies during treatment with natalizumab: 2-year results from AFFIRM and SENTINEL

This Podcast for the Neurology Journal begins with Dr. John H. Noseworthy, Editor-in-Chief briefly discussing highlighted articles from the print issue of Neurology. In the second segment Dr. Mark Freedman & Dr. Ellis Hedaya interview Dr. Peter Calabresi from John Hopkins University about his paper on anti-natalizumab antibodies. The podcast concludes with Dr. Robb M. Snider interviewing Dr. James J. Lah for the Lesson of the Week. Podcast participants had nothing to disclose except for Dr. Peter Calabresi who has received grant support in excess of $10,000 from Biogen Idec for other research/ activities not reported in this artic Read More

Download this Episode

Episode Segments

Intro (00:26 - 06:43)
00:26 06:43

Play Segment

Interview-anti-natalizumab antibodies (06:44 - 35:36)
LOTW-Natalizumab (35:37 - 46:30)

Log On

MEMBER LOG IN

Forgot password?

**Due to required system maintenance on AAN.com, some functions may be unavailable Friday, 12/15/2017, through Monday, 12/18/2017. Thank you for your patience.**